Patent details

EP3518933 Title: METHODS OF TREATING UTERINE FIBROIDS AND ENDOMETRIOSIS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3518933
WO Application Number:
EP2017074907
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17823018.1
WO Publication Number:
WO2018060501
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
29/09/2017
Grant date:
16/03/2022
EP Publication Date:
07/08/2019
WO Publication Date:
05/04/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
18/05/2022
Claims Translation B2 Received Date:
11/04/2025
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
16/03/2022
EP B1 Publication Date:
16/03/2022
EP B2 Publication Date:
26/02/2025
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
28/09/2037
Lapsed By Expiration Date:
Patent Validated Date:
24/04/2025
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
17/05/2024
 
 

 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1 Doshomachi 4-chome Chuo-ku, OSAKA-SHI, OSAKA 541-0045, Japan (JP)

From:
17/05/2024
 
 

 

Name:
Sumitomo Pharma Switzerland GmbH
Address:
Aeschengraben 27, 4051, Basel, Switzerland (CH)

Historical Applicant/holder

From:
26/01/2023
To:
17/05/2024

 

Name:
Myovant Sciences GmbH
Address:
Aeschengraben 27 Floor 22, 4051, Basel, Switzerland (CH)

From:
16/03/2022
To:
26/01/2023

 

Name:
Myovant Sciences GmbH
Address:
Viaduktstrasse 8, 4051 Basel, Switzerland (CH)

From:
16/03/2022
To:
17/05/2024

 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1 Doshomachi 4-chome Chuo-ku, OSAKA-SHI, OSAKA 541-0045, Japan (JP)

Agent

1

Name:
ir. B.Ch. Ledeboer c.s
From:
23/04/2025
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

2

Name:
ir. H.A. Witmans c.s.
From:
25/05/2022
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
23/04/2025

Inventor

1

Name:
JOHNSON, Brendan Mark
Address:
Chapel Hill North Carolina, 27514, United States of America (US)

2

Name:
SEELY, Lynn
Address:
San Mateo California, 94402, United States of America (US)

3

Name:
MUDD, JR., Paul N.
Address:
Cary North Carolina 27519, United States of America (US)

4

Name:
WOLLOWITZ, Susan
Address:
Lafayette California 94549, United States of America (US)

5

Name:
HIBBERD, Mark
Address:
Liss Hampshire GU33 6NQ, United Kingdom (GB)

6

Name:
TANIMOTO, Masataka
Address:
Osaka-shi Osaka 540-8645, Japan (JP)

7

Name:
RAJASEKHAR, Vijaykumar Reddy
Address:
Apple Valley California 92308, United States of America (US)

8

Name:
SUKHATME, Mayukh Vasant
Address:
New York New York, 10018, United States of America (US)

Priority

1

Priority Patent Number:
201762528409 P
Priority Date:
03/07/2017
Priority Country:
United States of America (US)

2

Priority Patent Number:
201762492839 P
Priority Date:
01/05/2017
Priority Country:
United States of America (US)

3

Priority Patent Number:
201662402150 P
Priority Date:
30/09/2016
Priority Country:
United States of America (US)

4

Priority Patent Number:
201662402055 P
Priority Date:
30/09/2016
Priority Country:
United States of America (US)

5

Priority Patent Number:
201662402034 P
Priority Date:
30/09/2016
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/513; A61K 31/565; A61K 31/57; A61P 15/00;

Publication

Bulletin

1

Bulletin Heading:
EP5
Journal edition number:
18/25
Publication date:
30/04/2025
Description:
European patents granted in amended form for the Netherlands in which an amended translation was filed ex Article 52 par. 6 of the NL Patent Law 1995

2

Bulletin Heading:
EP4
Journal edition number:
09/25
Publication date:
26/02/2025
Description:
European patents granted in amended form for the Netherlands

3

Bulletin Heading:
MED
Journal edition number:
09/25
Publication date:
26/02/2025
Description:
Other communications

4

Bulletin Heading:
CO
Journal edition number:
22/24
Publication date:
29/05/2024
Description:
Changes in the Netherlands Patent Register

5

Bulletin Heading:
VB1
Journal edition number:
03/23
Publication date:
18/01/2023
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

6

Bulletin Heading:
EP3
Journal edition number:
22/22
Publication date:
01/06/2022
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

7

Bulletin Heading:
EP2
Journal edition number:
11/22
Publication date:
16/03/2022
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202509
Publication date:
26/02/2025
Description:
Patent maintained (B2 publication)

2

Issue number:
202303
Publication date:
18/01/2023
Description:
Opposition procedure started

3

Issue number:
202302
Publication date:
11/01/2023
Description:
Inventor(s) changed

4

Issue number:
202217
Publication date:
27/04/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

5

Issue number:
202211
Publication date:
16/03/2022
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202400923A
Date Registered:
17/05/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1 Doshomachi 4-chome Chuo-ku, OSAKA-SHI, OSAKA 541-0045, Japan (JP)

2

Name:
Sumitomo Pharma Switzerland GmbH
Address:
Aeschengraben 27, 4051, Basel, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202300227A
Date Registered:
26/01/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
A. Rivière
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/09/2025
Annual Fee Number:
9
Annual Fee Amount:
340 Euro
Last Annual Payment Date:
26/09/2024
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
280 Euro
Payer:
Computer Packages Inc. (CPI)
Filing date Document type Document Description Number of pages File Type
23/04/2025 Outgoing Correspondence Letter no formal defects 1 PDF /0/1/4/5/7/0800775410/docs/ep17823018.1_2_653388l271.pdf
11/04/2025 Claims First filed claims 2 PDF /0/1/4/5/7/0800775410/docs/ep17823018.1_3_claims20250411124528799.pdf
25/05/2022 Outgoing Correspondence Letter no formal defects 1 PDF /0/1/4/5/7/0800775410/docs/ep17823018.1_0_482934l271.pdf
18/05/2022 Claims First filed claims 2 PDF /0/1/4/5/7/0800775410/docs/ep17823018.1_1_claims20220518184519933.pdf